Trial Profile
A multicenter, randomized, double-blind, double dummy, group-comparative trial to compare the effects of Livial [tibolone] and Activelle [Ethinylestradiol/norethisterone] on the vaginal bleeding pattern, vasomotor complaints, vaginal atrophy, QoL [quality of life] and sexual function
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2022
Price :
$35
*
At a glance
- Drugs Tibolone (Primary) ; Estradiol/norethisterone
- Indications Menopausal syndrome; Menopause
- Focus Adverse reactions; Therapeutic Use
- Sponsors Organon
- 06 Oct 2009 Additional lead trial centre and sponsor (Schering-Plough) identified as reported by ClinicalTrials.gov.
- 08 Mar 2007 New trial record.